Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 5, 1993
Issued Date -
N/A
app pub date -
Nov 27, 1991
filing date -
May 7, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of using an imidazoline compound, which is a vasodilator and an alpha-adrenergic blocking agent, for the treatment of symptoms of chronic obstructive pulmonary diseases (COPD), including cystic fibrosis, chronic bronchitis and emphysema, or COPD where it is associated with asthma, comprises administering the imidazoline to a patient by inhalation. Preferably, the imidazoline compound employed is tolazoline. The presentation of an imidazoline compound in a device for the administration of an aerosol is disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully